Such a functional consequence would offer the development of predictive biomarkers based on a stable analyte (i.e., DNAm) which can be efficiently detected in bodily liquids like urine, in analogy to the here exemplarily identified and validated DDR lead candidate gene RBBP8/CtiP in BLCA. The gene discussed is RBBP8; the disease is bladder transitional cell carcinoma.